Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls.
about
Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal bloodLiquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acidsCell-free circulating tumor DNA in cancerNew findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?Guide to detecting epidermal growth factor receptor (EGFR) mutations in ctDNA of patients with advanced non-small-cell lung cancerNormal and Cancerous Tissues Release extrachromosomal circular DNA (eccDNA) into the Circulation.Detection and isolation of circulating exosomes and microvesicles for cancer monitoring and diagnostics using micro-/nano-based devices.Extracellular plasma RNA from colon cancer patients is confined in a vesicle-like structure and is mRNA-enriched.Methylation patterns of cell-free plasma DNA in relapsing-remitting multiple sclerosis.Diversity of Precursor Lesions For Pancreatic Cancer: The Genetics and Biology of Intraductal Papillary Mucinous NeoplasmThe feasibility of using mutation detection in ctDNA to assess tumor dynamics.Liquoral liquid biopsy in neoplastic meningitis enables molecular diagnosis and mutation tracking: a proof of concept.Hypermethylation of tumor suppressor genes involved in critical regulatory pathways for developing a blood-based test in breast cancer.Circulating Tumor Nucleic Acids: Perspective in Breast Cancer.Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts.Detection and quantification of mutations in the plasma of patients with colorectal tumors.Serum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various gradesTowards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantificationCirculating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer.Plasma tumor DNA: on your markers, get set, go!K-ras mutation and p16 and preproenkephalin promoter hypermethylation in plasma DNA of pancreatic cancer patients: in relation to cigarette smoking.Effective posttransplant antitumor immunity is associated with TLR-stimulating nucleic acid-immunoglobulin complexes in humans.Mass spectrometric based analysis, characterization and applications of circulating cell free DNA isolated from human body fluidsResults of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancerDo circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathologyThe awakening of an advanced malignant cancer: an insult to the mitochondrial genomeDNA markers in molecular diagnostics for hepatocellular carcinoma.Circulating DNA and Micro-RNA in Patients with Pancreatic Cancer.Quantitative analysis of cell-free DNA in the plasma of gastric cancer patients.Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation.Circulating tumor DNA: a resuscitative gold mine?Prediction of cancer progression in a group of 73 gastric cancer patients by circulating cell-free DNA.Circulating Cell-Free DNA in Dogs with Mammary Tumors: Short and Long Fragments and Integrity Index.Modified isocratic capillary electrophoresis detection of cell-free DNA in semenNon-Invasive Detection of Esophageal Cancer using Genetic Changes in Circulating Cell-Free DNA.Serum-based DNA methylation biomarkers in colorectal cancer: potential for screening and early detection.Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors.Non-invasive Prenatal Testing: Technologies, Clinical Assays and Implementation Strategies for Women's Healthcare Practitioners.Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer.Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology.
P2860
Q24657306-5C12319B-D5B4-4B33-88B6-6BDBF01B7FD5Q26739062-B2A530B9-4DBB-49C3-A158-A34761CA6A6FQ26750899-54A4949E-6124-41E3-A2E6-7252C3B4F3A1Q26796348-DF622188-0252-4B5E-9007-5B7DC6C0FEFEQ28079253-1D525359-26DE-46A9-882E-DE489B22DF51Q30252331-6D4D5116-6F09-4FB5-8E46-24E71D5A7FBDQ30365308-401C0AB1-B55C-4E5A-A938-5C1E7F9F1839Q33331704-60DAC89E-077B-4483-A2CC-03E52E5EF301Q33625018-61677CEA-0DC7-40D8-A77D-78170D1C5A6EQ33635144-052FA8AD-DA51-4393-BDCB-C8D8A2AED922Q33697983-2FC17135-7B43-4C84-8F73-833D1BB95E4DQ33778007-28C70789-0BA6-42A4-A735-3DE0ED1D68BDQ33808960-7A455D45-D17B-4EFF-A895-0A39BB037483Q34096001-5FB01DC5-3CBC-42E8-A6DD-3BDD6582E294Q34117027-0378B876-090F-445C-A82C-487C7FFFCE03Q34132363-4D494E2F-4B27-4C7A-A38F-31CBFFFC9722Q34132740-E367BF59-0419-4075-8968-BBEF12188E84Q34277946-2E043D85-440A-485A-961B-C7C321873041Q34354622-01B9B209-CC62-4680-B9DE-A42FB1B01C8CQ34357908-2A79BD22-C2D6-41CC-929A-B9A940FF780CQ34596601-B82EDAC3-3B17-4545-B17B-54441D3E871CQ34755262-E49662CF-2943-4532-A537-00E3B4C509EFQ35099257-181D1ABD-9A00-4D2D-AB3B-0E78C83FACAFQ35194151-6C722F6F-D2A1-4085-A381-FF405A1728CEQ35543094-A0A871A1-069B-455C-B843-115ED17032F7Q35718294-C9E7313A-776E-4DC8-BFDD-BE7C8370C331Q35781255-6F453A52-6BBC-4569-99FD-06FA12B33C3BQ35828060-B4BAE663-C0B5-4236-BDF1-AAF46F9828B8Q35995428-45D80CFB-59AE-4EED-B197-1C1C1366474BQ36008206-A27542B9-305A-43CE-A3B3-1F9DFFF60C2BQ36204919-67F4817A-1154-4F98-B18A-00E970EB15ECQ36219131-062A2B89-4EC6-49EC-8F7A-4406BF5ECD0EQ36247593-5DEF8F5F-C2B6-4A79-BE17-307283735591Q36272058-39DA089F-AAB7-423D-A127-EB0DFAAA3D11Q36571431-F55AE4D2-ADED-4B70-AA24-6CBF4CEA3C43Q36646536-07EB22FD-74D1-4E21-8411-32CF584DBDD3Q36815383-125E112B-F7D1-4764-97DF-82481D40578AQ36847554-E0B6D356-666A-465A-9E7C-01D534A6728FQ36898870-EB36C0C0-69A8-41B0-A745-1ACB39F72CFBQ37014663-CDA04CBF-0F42-489D-8C5F-A8AB9D3845DE
P2860
Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Cell-free DNA in human blood p ...... c cancer and healthy controls.
@en
Cell-free DNA in human blood p ...... c cancer and healthy controls.
@nl
type
label
Cell-free DNA in human blood p ...... c cancer and healthy controls.
@en
Cell-free DNA in human blood p ...... c cancer and healthy controls.
@nl
prefLabel
Cell-free DNA in human blood p ...... c cancer and healthy controls.
@en
Cell-free DNA in human blood p ...... c cancer and healthy controls.
@nl
P2093
P1433
P1476
Cell-free DNA in human blood p ...... c cancer and healthy controls.
@en
P2093
P577
1998-07-01T00:00:00Z